Solid Biosciences (SLDB)
US Market

Solid Biosciences Stock Analysis & Ratings

SLDB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.42 - $3.76
Previous Close$0.58
Average Volume (3M)837.20K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.8
Next EarningsAug 16, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Solid Biosciences’s price range in the past 12 months?
Solid Biosciences lowest stock price was $0.42 and its highest was $3.76 in the past 12 months.
    What is Solid Biosciences’s market cap?
    Currently, no data Available
    What is Solid Biosciences’s price target?
    The average price target for Solid Biosciences is $5.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $12.00 ,the lowest forecast is $2.00. The average price target represents 898.26% Increase from the current price of $0.576.
      What do analysts say about Solid Biosciences?
      Solid Biosciences’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
        When is Solid Biosciences’s upcoming earnings report date?
        Solid Biosciences’s upcoming earnings report date is Aug 16, 2022 which is in 42 days.
          How were Solid Biosciences’s earnings last quarter?
          Solid Biosciences released its earnings results on Apr 27, 2022. The company reported -$0.22 earnings per share for the quarter, missing the consensus estimate of -$0.194 by -$0.026.
            Is Solid Biosciences overvalued?
            According to Wall Street analysts Solid Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Solid Biosciences pay dividends?
              Solid Biosciences does not currently pay dividends.
              What is Solid Biosciences’s EPS estimate?
              Solid Biosciences’s EPS estimate is -$0.21.
                How many shares outstanding does Solid Biosciences have?
                Solid Biosciences has 112,811,870 shares outstanding.
                  What happened to Solid Biosciences’s price movement after its last earnings report?
                  Solid Biosciences reported an EPS of -$0.22 in its last earnings report, missing expectations of -$0.194. Following the earnings report the stock price went down -17.949%.
                    Which hedge fund is a major shareholder of Solid Biosciences?
                    Among the largest hedge funds holding Solid Biosciences’s share is Perceptive Advisors LLC. It holds Solid Biosciences’s shares valued at 16M.


                      Solid Biosciences Stock Analysis

                      The Solid Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Solid Biosciences

                      Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

                      Similar Stocks
                      Price & Change
                      Meiragtx Holdings
                      Voyager Therapeutics
                      Wave Life Sciences

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis